|4Oct 17, 4:01 PM ET

Aggarwal Sumit 4

4 · Eloxx Pharmaceuticals, Inc. · Filed Oct 17, 2024

Insider Transaction Report

Form 4
Period: 2024-10-16
Transactions
  • Award

    Common Stock

    2024-10-16+165,000169,930 total
Footnotes (1)
  • [F1]This restricted stock award was made under the Issuer's 2018 Equity Incentive Plan and vests as to 25% on October 16, 2025 and in 12 substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.

Documents

1 file
  • 4
    tm2426349-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT